Menu
Menu
Alembic Pharmaceuticals has received USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, a key treatment for hypertension. This approval allows Alembic to offer an affordable alternative to patients, enhancing access to essential cardiovascular care while expanding its presence in the U.S. generic drug market.